Nutt DJ

Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, https://ror.org/041kmwe10Imperial College London, London, UK.

14 preprints · 65 papers · ORCID

PreprintKetamine

No Heavy Drinking Days and Percentage of Days Abstinent in a Randomized Trial of Adjunctive Ketamine for Alcohol Use Disorder: Secondary Analysis of the KARE Trial

Morgan CJ, Nutt DJ

Europe PMC2026
ArticlePsilocybin

Psilocybin therapy for adult females with anorexia nervosa: pilot study.

Douglass HM, Spriggs MJ, Godfrey K +17

Europe PMC2026
ArticlePsilocybin

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.

Pasquini L, Vohryzek J, Escrichs A +12

Europe PMC2026
PreprintPsilocybin

Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram

Dagnino PC, Acero-Pousa I, Carhart-Harris RL +5

Europe PMC2026
ArticleMDMA

Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation.

Liberati E, Curran HV, Fonagy P +6

Europe PMC2026
PreprintPsilocybin

Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem

Dagnino PC, Acero-Pousa I, Zamora-López G +7

Europe PMC2026
ArticlePsilocybin

Exploring new avenues: Psychedelic-assisted therapy for young people.

Vamvakopoulou IA, Nicholls D, Nutt DJ +1

Europe PMC2026
ArticlePsilocybin

Human brain changes after first psilocybin use.

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2026
ArticlePsilocybin

An international mega-analysis of psychedelic drug effects on brain circuit function.

Girn M, Doss MK, Roseman L +24

Europe PMC2026
ArticlePsilocybin

Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations.

Yonezawa K, Hirata M, Takano H +7

Europe PMC2026
ArticleMDMA

Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects.

Ertl N, Ashraf I, Azizi L +5

Europe PMC2026
ArticleKetamine

A long, strange trip: Ketamine treatment in psychiatry.

Nutt DJ, Morgan C, Erritzoe D +2

Europe PMC2025
ArticlePsilocybin

Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatment.

Socoró-Garrigosa M, Perl YS, Kringelbach ML +5

Europe PMC2025
ArticlePsilocybin

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.

Henry J, Giribaldi B, Nutt DJ +3

Europe PMC2025
ArticlePsilocybin

Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.

Roseby W, Kettner H, Roseman L +7

Europe PMC2025
ArticlePsilocybin

Serotonergic psychedelics for depression: A comprehensive overview.

Wingert AM, Agnorelli C, Peill J +3

Europe PMC2025
ArticlePsilocybin

Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.

Wall MB, Demetriou L, Giribaldi B +5

Europe PMC2025
ArticleMDMA

MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up.

Thurgur H, Sessa B, Higbed L +6

Europe PMC2025
ArticleLSD

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State.

Coleman CR, Shinozuka K, Tromm R +7

Europe PMC2025
PreprintLSD

LSD reconfigures the frequency-specific network landscape of the human brain

Shinozuka K, Rosso M, Coleman CR +8

Europe PMC2025
PreprintPsilocybin

The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial

Henry J, Giribaldi B, Nutt DJ +3

Europe PMC2025
PreprintMDMA

Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects

Ertl N, Ashraf I, Azizi L +5

Europe PMC2025
ArticleLSD

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics.

Shinozuka K, Tewarie PKB, Luppi A +7

Europe PMC2025
ArticlePsilocybin

The Australia story: Current status and future challenges for the clinical applications of psychedelics.

Nutt DJ, Hunt P, Schlag AK +1

Europe PMC2026
PreprintLSD

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State

Coleman CR, Shinozuka K, Tromm R +7

Europe PMC2024
PreprintPsilocybin

Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits

Pasquini L, Vohryzek J, Escrichs A +12

Europe PMC2024
ArticlePsychedelics

Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics.

Wall MB, Harding R, Ertl N +6

Europe PMC2024
ArticlePsilocybin

Psychedelics: From Cave Art to 21st-Century Medicine for Addiction.

Vamvakopoulou IA, Nutt DJ

Europe PMC2024
ArticleDMT

Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being.

Bonnelle V, Feilding A, Rosas FE +3

Europe PMC2024
ArticlePsychedelics

Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms.

Vignando M, Ffytche D, Mazibuko N +11

Europe PMC2024
PreprintLSD

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics

Shinozuka K, Tewarie PK, Luppi A +7

Europe PMC2024
ArticleDMT

The flattening of spacetime hierarchy of the <i>N,N</i>-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework.

Vohryzek J, Cabral J, Timmermann C +6

Europe PMC2024
ArticlePsychedelics

A Perspective on Psychedelics as Treatments for Addictions.

Nutt DJ, Morgan C, Klaire S

Europe PMC2024
ArticlePsilocybin

Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.

Erritzoe D, Barba T, Spriggs MJ +3

Europe PMC2024
PreprintDMT

Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing

Bonnelle V, Feilding A, Rosas FE +3

Europe PMC2024
ArticlePsilocybin

Brain dynamics predictive of response to psilocybin for treatment-resistant depression.

Vohryzek J, Cabral J, Lord LD +6

Europe PMC2024
ArticleDMT

Effects of DMT on mental health outcomes in healthy volunteers.

Timmermann C, Zeifman RJ, Erritzoe D +2

Europe PMC2024
ArticlePsilocybin

Psychedelics and sexual functioning: a mixed-methods study.

Barba T, Kettner H, Radu C +6

Europe PMC2024
ArticlePsychedelics

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

Barbut Siva J, Barba T, Kettner H +4

Europe PMC2024
ArticleLSD

Effects of External Stimulation on Psychedelic State Neurodynamics.

Mediano PAM, Rosas FE, Timmermann C +10

Europe PMC2024
ArticlePsilocybin

Psilocybin and Other Classic Psychedelics in Depression.

Nutt DJ, Peill JM, Weiss B +3

Europe PMC2024
ArticleDMT

Psychological and physiological effects of extended DMT.

Luan LX, Eckernäs E, Ashton M +10

Europe PMC2024
ArticleLSD

LSD-induced changes in the functional connectivity of distinct thalamic nuclei.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +10

Europe PMC2023
ArticlePsilocybin

Neuroimaging in psychedelic drug development: past, present, and future.

Wall MB, Harding R, Zafar R +3

Europe PMC2023
PreprintDMT

Harmonic decomposition of spacetime (HADES) framework characterises the spacetime hierarchy of the DMT brain state

Vohryzek J, Cabral J, Timmermann C +6

Europe PMC2023
ArticlePsilocybin

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.

Simonsson O, Carlbring P, Carhart-Harris R +5

Europe PMC2023
ArticlePsychedelics

Psychedelic therapy in the treatment of addiction: the past, present and future.

Zafar R, Siegel M, Harding R +7

Europe PMC2023
ArticlePsilocybin

Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model.

McCrone P, Fisher H, Knight C +4

Europe PMC2023
ArticlePsilocybin

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.

Weiss B, Ginige I, Shannon L +8

Europe PMC2024
ArticlePsilocybin

Increased low-frequency brain responses to music after psilocybin therapy for depression.

Wall MB, Lam C, Ertl N +4

Europe PMC2023
ArticleLSD

Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +8

Europe PMC2023
ArticleDMT

Human brain effects of DMT assessed via EEG-fMRI.

Timmermann C, Roseman L, Haridas S +12

Europe PMC2023
ArticlePsilocybin

Canalization and plasticity in psychopathology.

Carhart-Harris RL, Chandaria S, Erritzoe DE +11

Europe PMC2023
ArticleLSD

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans.

Kanen JW, Luo Q, Rostami Kandroodi M +5

Europe PMC2023
ArticlePsilocybin

Body mass index (BMI) does not predict responses to psilocybin.

Spriggs MJ, Giribaldi B, Lyons T +9

Europe PMC2023
ArticlePsilocybin

A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.

Nayak SM, Bari BA, Yaden DB +7

Europe PMC2023
ArticleMescaline

Mescaline: The forgotten psychedelic.

Vamvakopoulou IA, Narine KAD, Campbell I +2

Europe PMC2023
ArticlePsilocybin

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.

Singleton SP, Luppi AI, Carhart-Harris RL +7

Europe PMC2022
ArticlePsilocybin

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.

Barba T, Buehler S, Kettner H +6

Europe PMC2022
ArticlePsilocybin

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.

Nygart VA, Pommerencke LM, Haijen E +6

Europe PMC2022
PreprintPsilocybin

Brain dynamics predictive of response to psilocybin for treatment-resistant depression

Vohryzek J, Cabral J, Lord L +6

Europe PMC2022
PreprintPsilocybin

Increased low-frequency brain responses to music after psilocybin therapy for depression

Wall MB, Lam C, Ertl N +4

Europe PMC2022
ArticlePsilocybin

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.

Schlag AK, Aday J, Salam I +2

Europe PMC2022
ArticleKetamine

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review.

Walsh Z, Mollaahmetoglu OM, Rootman J +5

Europe PMC2021
ArticlePsilocybin

Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".

Spriggs MJ, Douglass HM, Park RJ +11

Europe PMC2021
PreprintPsilocybin

LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory

Singleton SP, Luppi AI, Carhart-Harris RL +7

Europe PMC2021
ArticlePsychedelics

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Carhart-Harris RL, Wagner AC, Agrawal M +5

Europe PMC2022
ArticlePsychedelics

Self-blinding citizen science to explore psychedelic microdosing.

Szigeti B, Kartner L, Blemings A +5

Europe PMC2021
ArticlePsilocybin

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.

Andersen KAA, Carhart-Harris R, Nutt DJ +1

Europe PMC2021
ArticleDMT

DMT alters cortical travelling waves.

Alamia A, Timmermann C, Nutt DJ +2

Europe PMC2020
ArticleDMT

Neural correlates of the DMT experience assessed with multivariate EEG.

Timmermann C, Roseman L, Schartner M +13

Europe PMC2019
ArticlePsilocybin

Effects of psilocybin therapy on personality structure.

Erritzoe D, Roseman L, Nour MM +4

Europe PMC2018
ArticlePsilocybin

Psychiatry &amp; the psychedelic drugs. Past, present &amp; future.

Rucker JJH, Iliff J, Nutt DJ

Europe PMC2018
ArticleLSD

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Timmermann C, Spriggs MJ, Kaelen M +5

Europe PMC2018
ArticlePsilocybin

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ +13

Europe PMC2018
ArticlePsychedelics

Serotonin and brain function: a tale of two receptors.

Carhart-Harris RL, Nutt DJ

Europe PMC2017
ArticleLSD

LSD-induced entropic brain activity predicts subsequent personality change.

Lebedev AV, Kaelen M, Lövdén M +4

Europe PMC2016
ArticleLSD

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Roseman L, Sereno MI, Leech R +6

Europe PMC2016
ArticleLSD

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L +23

Europe PMC2016